STOCK TITAN

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

MALVERN, Pa., June 14, 2021 – TELA Bio, Inc. (NASDAQ: TELA) announced its participation in the JMP Securities Life Sciences Conference. The presentation is scheduled for June 16, 2021, at 11:30 AM EDT. Interested parties can access the live and archived webcast at ir.telabio.com. TELA Bio focuses on innovative tissue reinforcement materials for soft tissue reconstruction, aiming to enhance clinical outcomes and minimize the use of permanent synthetic materials.

Positive
  • None.
Negative
  • None.

MALVERN, Pa., June 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company will participate in the JMP Securities Life Sciences Conference.

TELA Bio's management is scheduled to present at the JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 11:30 AM EDT. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com


FAQ

When will TELA Bio present at the JMP Securities Life Sciences Conference?

TELA Bio will present on June 16, 2021, at 11:30 AM EDT.

How can I access the TELA Bio conference presentation?

The presentation can be accessed live and archived at ir.telabio.com.

What is TELA Bio's focus in the medical technology sector?

TELA Bio focuses on designing and marketing innovative tissue reinforcement materials for soft tissue reconstruction.

What products does TELA Bio offer for tissue reinforcement?

TELA Bio offers OviTex® and OviTex PRS Reinforced Tissue Matrix products specifically for hernia repair and abdominal wall reconstruction.

What stock symbol is associated with TELA Bio?

TELA Bio is traded under the stock symbol 'TELA' on NASDAQ.

TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

113.83M
34.43M
4.49%
51.75%
1.22%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN